Urotensin II evokes neurotransmitter release from rat cerebrocortical slices

Neuroscience Letters

Volumn 440, Issue 3, 2008, Pages 275-279

  Ono, Tomoko ^a   Kawaguchi, Yoko ^a   Kudo, Mihoko ^a   Kushikata, Tetsuya ^a   Hashiba, Eiji ^a   Yoshida, Hitoshi ^a   Kudo, Tsuyoshi ^a   Furukawa, Kenichi ^b   Douglas, Stephen A ^c   Guerrini, Remo ^d   Calo', Girolamo ^e   Hirota, Kazuyoshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c GLAXOSMITHKLINE   (United States)

^d Biotechnology Centre   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

Author keywords

HEK293 rUT cells; Norepinephrine; Rat cerebrocortical slices; UFP 803; Urotensin II; UT receptor

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DOPAMINE; GLUTAMIC ACID; HISTAMINE; SEROTONIN; UFP 803; UROTENSIN II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG EFFECT; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; WAKEFULNESS;

EID: 45849086109     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.05.096     Document Type: Article

References (26)

1. Aiyar N., Johns D.G., Ao Z., Disa J., Behm D.J., Foley J.J., Buckley P.T., Sarau H.M., van-der-Keyl H.K., Elshourbagy N.A., and Douglas S.A. Cloning and pharmacological characterization of the cat urotensin-II receptor (UT). Biochem. Pharmacol. 69 (2005) 1069-1079
2. Brailoiu E., Brailoiu G.C., Miyamoto M.D., and Dun N.J. The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals. Br. J. Pharmacol. 138 (2003) 1580-1588
3. Camarda V., Guerrini R., Kostenis E., Rizzi A., Calo' G., Hattenberger A., Zucchini M., Salvadori S., and Regoli D. A new ligand for the urotensin II receptor. Br. J. Pharmacol. 137 (2002) 311-314
4. Camarda V., Song W., Marzola E., Spagnol M., Guerrini R., Salvadori S., Regoli D., Thompson J.P., Rowbotham D.J., Behm D.J., Douglas S.A., Calo' G., and Lambert D.G. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors. Eur. J. Pharmacol. 498 (2004) 83-86
5. 8]urotensin II(4-11) (UFP-803). Br. J. Pharmacol. 147 (2006) 92-100
6. Castel H., Diallo M., Chatenet D., Leprince J., Desrues L., Schouft M.T., Fontaine M., Dubessy C., Lihrmann I., Scalbert E., Malagon M., Vaudry H., Tonon M.C., and Gandolfo P. Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J. Neurochem. 99 (2006) 582-595
7. 50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
8. Chu M., Huang Z.L., Qu W.M., Eguchi N., Yao M.H., and Urada Y. Extracellular histamine level in the frontal cortex is positively correlated with the amount of wakefulness in rats. Neurosci. Res. 49 (2004) 417-420
9. Clark S.D., Nothacker H.P., Blaha C.D., Tyler C.J., Duangdao D.M., Grupke S.L., Helton D.R., Leonard C.S., and Civelli O. Urotensin II acts as a modulator of mesopontine cholinergic neurons. Brain Res. 1059 (2005) 139-148
10. Coulouarn Y., Jegou S., Tostivint H., Vaudry H., and Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett. 457 (1999) 28-32
11. de Lecea L., and Bourgin P. Neuropeptide interactions and REM sleep: a role for urotensin II?. Peptides 29 (2008) 845-851
12. do Rego J.C., Leprince J., Scalbert E., Vaudry H., and Costentin J. Behavioral actions of urotensin-II. Peptides 29 (2008) 838-844
13. Hirota K., Kushikata T., Kudo M., Kudo T., Lambert D.G., and Matsuki A. Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br. J. Pharmacol. 134 (2001) 1461-1466
14. Horie S., Yasuda S., Tsurumaki Y., Someya A., Saito T., Okuma Y., Nomura Y., Hirabayashi T., and Murayama T. Contraction of isolated guinea-pig ileum by urotensin II via activation of ganglionic cholinergic neurons and acetylcholine release. Neuropharmacology 45 (2003) 1019-1027
15. Huitron-Resendiz S., Kristensen M.P., Sánchez-Alavez M., Clark S.D., Grupke S.L., Tyler C., Suzuki C., Nothacker H.P., Civelli O., Criado J.R., Henriksen S.J., Leonard C.S., and de Lecea L. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J. Neurosci. 25 (2005) 5465-5474
16. Jacobs B.L. Overview of the activity of brain monoaminergic neurons across the sleep-wake cycle. In: Sleep: A., Wauquier J.M., Gaillard J.M., Monti M., and Radulovacki (Eds). Neurotransmitters and Neuromodulators (1985), Raven Press, New York 1-14
17. Jegou S., Cartier D., Dubessy C., Gonzalez B.J., Chatenet D., Tostivint H., Scalbert E., LePrince J., Vaudry H., and Lihrmann I. Localization of the urotensin II receptor in the rat central nervous system. J. Comp. Neurol. 495 (2006) 21-36
18. Léna I., Parrot S., Deschaux O., Muffat-Joly S., Renaud B., Suaud-Chagny M.F., and Gottesmann C. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J. Neurosci. Res. 81 (2005) 891-899
19. Lin J.S., Hou Y., Sakai K., and Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J. Neurosci. 16 (1996) 1523-1537
20. Lopez-Rodriguez F., Medina-Ceja L., Wilson C.L., Jhung D., and Morales-Villagran A. Changes in extracellular glutamate levels in rat orbitofrontal cortex during sleep and wakefulness. Arch. Med. Res. 38 (2007) 52-55
21. Mori M., and Fujino M. Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain. Peptides 25 (2004) 1815-1818
22. Nutt D.J., Lalies M.D., Lion L.A., and Hudson A.L. Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharmacol. 11 (1997) 163-168
23. Portas C.M., Bjorvatn B., Fagerland S., Grønli J., Mundal V., Sørensen E., and Ursin R. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience 83 (1998) 807-814
24. Sugo T., Murakami Y., Shimomura Y., Harada M., Abe M., Ishibashi Y., Kitada C., Miyajima N., Suzuki N., Mori M., and Fujino M. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem. Biophys. Res. Commun. 310 (2003) 860-868
25. Szabadi E. Drugs for sleep disorders: mechanisms and therapeutic prospects. Br. J. Clin. Pharmacol. 61 (2006) 761-766
26. Watson A.M., and May C.N. Urotensin II, a novel peptide in central and peripheral cardiovascular control. Peptides 25 (2004) 1759-1766